Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis.
about
Ursodeoxycholic acid for primary biliary cirrhosisBile acids in treatment of ocular diseaseChanges in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob miceChemical chaperone TUDCA prevents apoptosis and improves survival during polymicrobial sepsis in miceCombined effects of tauroursodeoxycholic Acid and glutamine on bacterial translocation in obstructive jaundiced rats:Ursodeoxycholic acid is conjugated with taurine to promote secretin-stimulated biliary hydrocholeresis in the normal rat.Ursodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survival.A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbationA multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis.Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid.Application of Tauroursodeoxycholic Acid for Treatment of Neurological and Non-neurological Diseases: Is There a Potential for Treating Traumatic Brain Injury?Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.Increased monocyte-derived reactive oxygen species in type 2 diabetes: role of endoplasmic reticulum stressEfficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: a double-blind randomized controlled trial.Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load.Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate.Endoplasmic reticulum stress in the pathogenesis of hypertension.Biopsy-derived Intestinal Epithelial Cell Cultures for Pathway-based Stratification of Patients With Inflammatory Bowel Disease.Tauroursodeoxycholic acid affects PPARγ and TLR4 in Steatotic liver transplantation.
P2860
Q24202184-64ABC64F-9BAA-47C0-80A7-A11363EB5FE9Q24653326-07C49DC5-F720-425A-A871-60F9BACE4981Q28476015-8F0C1460-A167-4D21-B1B6-E008FFF5EDF2Q28822622-5074F17B-C144-4986-B3FF-ACF342CC9C85Q33974040-148AEDC2-CC65-4EED-BDF2-03C6A0ACF04EQ34110298-FDE3077E-3CE6-4CB7-933E-0CF63EC6F969Q36612947-BDF01034-B4D9-4ADE-B5ED-48C766CA67D9Q37383640-BF31F8E0-C442-421F-A5F5-826157693498Q37468171-0433C975-1714-407F-969C-A9FE15554153Q37681567-D0A8C4C7-A2A8-4600-A144-D1F1A79A24DEQ38694174-B92E051E-8771-492C-9A66-E43C1968C88EQ38738566-F5ADAC64-7A77-49A5-BD5D-86DD83C7A881Q39177176-A90349FA-EAC1-4140-A4E8-564715A8BEF2Q39228975-AE1044C3-F595-4750-8B1A-FBA707908B90Q40994822-734DCC2A-8E68-48C0-84D3-6C68A3F33BA3Q44111064-2D57EE6F-DC76-4E26-9E43-7EA5BD7A132DQ48292400-C27750AE-C6F9-46E4-AB78-B40F36EFBC37Q50065054-9628C499-013C-4198-B3A6-B78846606ABBQ50910081-B3CF435F-5283-4A54-84E1-3C692A8F7D2A
P2860
Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Metabolism of orally administe ...... ith primary biliary cirrhosis.
@en
Metabolism of orally administe ...... ith primary biliary cirrhosis.
@nl
type
label
Metabolism of orally administe ...... ith primary biliary cirrhosis.
@en
Metabolism of orally administe ...... ith primary biliary cirrhosis.
@nl
prefLabel
Metabolism of orally administe ...... ith primary biliary cirrhosis.
@en
Metabolism of orally administe ...... ith primary biliary cirrhosis.
@nl
P2093
P2860
P356
P1433
P1476
Metabolism of orally administe ...... with primary biliary cirrhosis
@en
P2093
A Crosignani
K D Setchell
P2860
P304
P356
10.1136/GUT.38.3.439
P407
P577
1996-03-01T00:00:00Z